SUZANA KALANICA: Open Payments
NPI 1245800820 · FARMINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 35 payments from 14 companies in 2025. Trend: 2023 $669 · 2024 $266 · 2025 $1,113
Food & beverage: $1,113
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 7 | $222 |
| GENZYME CORPORATION | 1 | $148 |
| Janssen Biotech, Inc. | 6 | $146 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $135 |
| Arcutis Biotherapeutics, Inc. | 1 | $119 |
| Galderma Laboratories, L.P. | 3 | $74 |
| Incyte Corporation | 3 | $66 |
| ABBVIE INC. | 3 | $54 |
| UCB, Inc. | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
Products named: ANZUPGO, DUPIXENT, TREMFYA, Leqselvi, NEMLUVIO, OPZELURA, RINVOQ, ADBRY.
Industry payments across CT — which companies pay providers there.
